Talbot K - Search Results

Year	Number of Results
1955	1
1961	1
1969	1
1974	1
1975	2
1976	1
1977	1
1979	2
1980	1
1981	2
1982	1
1983	2
1984	2
1985	1
1986	4
1987	1
1988	2
1989	1
1990	1
1992	2
1993	3
1994	1
1995	2
1996	5
1997	5
1998	4
1999	2
2000	1
2001	3
2002	2
2003	5
2004	4
2005	2
2006	7
2007	11
2008	12
2009	19
2010	23
2011	22
2012	21
2013	42
2014	37
2015	18
2016	29
2017	34
2018	26
2019	15
2020	30
2021	19
2022	22
2023	17
2024	8

1

The ALS-associated TDP-43M337V mutation dysregulates microglia-derived extracellular microRNAs in a sex-specific manner.

Christoforidou E, Moody L, Joilin G, Simoes FA, Gordon D, Talbot K, Hafezparast M. Christoforidou E, et al. Among authors: talbot k. Dis Model Mech. 2024 May 9:dmm.050638. doi: 10.1242/dmm.050638. Online ahead of print. Dis Model Mech. 2024. PMID: 38721655 Free article.

2

Recent insights from human induced pluripotent stem cell models into the role of microglia in amyotrophic lateral sclerosis.

Nikel LM, Talbot K, Vahsen BF. Nikel LM, et al. Among authors: talbot k. Bioessays. 2024 May 7:e2400054. doi: 10.1002/bies.202400054. Online ahead of print. Bioessays. 2024. PMID: 38713169

3

Venous thromboembolism risk in amyotrophic lateral sclerosis: a hospital record-linkage study.

Goldacre R, Trubshaw M, Morris EJA, Talbot K, Goldacre MJ, Thompson AG, Turner MR. Goldacre R, et al. Among authors: talbot k. J Neurol Neurosurg Psychiatry. 2024 Mar 28:jnnp-2024-333399. doi: 10.1136/jnnp-2024-333399. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 38548323 Free article.

4

Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates.

Young CA, Chaouch A, Mcdermott CJ, Al-Chalabi A, Chhetri SK, Talbot K, Harrower T, Orrell RW, Annadale J, Hanemann CO, Scalfari A, Tennant A, Mills R; TONIC-ALS STUDY GROUP. Young CA, et al. Among authors: talbot k. Amyotroph Lateral Scler Frontotemporal Degener. 2024 Mar 11:1-11. doi: 10.1080/21678421.2024.2322545. Online ahead of print. Amyotroph Lateral Scler Frontotemporal Degener. 2024. PMID: 38465877

5

Improving the measurement properties of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): deriving a valid measurement total for the calculation of change.

Young CA, Chaouch A, Mcdermott CJ, Al-Chalabi A, Chhetri SK, Talbot K, Malaspina A, Mills R, Tennant A. Young CA, et al. Among authors: talbot k. Amyotroph Lateral Scler Frontotemporal Degener. 2024 May;25(3-4):400-409. doi: 10.1080/21678421.2024.2322539. Epub 2024 Mar 1. Amyotroph Lateral Scler Frontotemporal Degener. 2024. PMID: 38426231 Free article.

6

Editorial Expression of Concern: Altered neuregulin 1-erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia.

Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH, Bakshi K, Kamins J, Borgmann-Winter KE, Siegel SJ, Gallop RJ, Arnold SE. Hahn CG, et al. Among authors: talbot k. Nat Med. 2024 Mar;30(3):911. doi: 10.1038/s41591-023-02757-y. Nat Med. 2024. PMID: 38114668 No abstract available.

7

Mutant GGGGCC RNA prevents YY1 from binding to Fuzzy promoter which stimulates Wnt/β-catenin pathway in C9ALS/FTD.

Chen ZS, Ou M, Taylor S, Dafinca R, Peng SI, Talbot K, Chan HYE. Chen ZS, et al. Among authors: talbot k. Nat Commun. 2023 Dec 18;14(1):8420. doi: 10.1038/s41467-023-44215-w. Nat Commun. 2023. PMID: 38110419 Free PMC article.

8

Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer's and Parkinson's diseases.

Rhea EM, Babin A, Thomas P, Omer M, Weaver R, Hansen K, Banks WA, Talbot K. Rhea EM, et al. Among authors: talbot k. Tissue Barriers. 2023 Dec 14:2292461. doi: 10.1080/21688370.2023.2292461. Online ahead of print. Tissue Barriers. 2023. PMID: 38095516

9

Data-independent acquisition proteomics of cerebrospinal fluid implicates endoplasmic reticulum and inflammatory mechanisms in amyotrophic lateral sclerosis.

Dellar ER, Vendrell I, Talbot K, Kessler BM, Fischer R, Turner MR, Thompson AG. Dellar ER, et al. Among authors: talbot k. J Neurochem. 2024 Feb;168(2):115-127. doi: 10.1111/jnc.16030. Epub 2023 Dec 12. J Neurochem. 2024. PMID: 38087504 Free PMC article.

10

Oseltamivir May or May Not Reduce Hospitalizations.

Antoon JW, Grijalva CG, Talbot K. Antoon JW, et al. Among authors: talbot k. JAMA Intern Med. 2024 Jan 1;184(1):116-117. doi: 10.1001/jamainternmed.2023.4720. JAMA Intern Med. 2024. PMID: 37983034 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

416 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

416 results

Results by year